Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Teva Pharmaceutical Industries Ltd. has reached settlements with Sandoz, Actavis, Lupin, and Apotex with respect to U. Patent 7,132,570 (the "570 patent") for Teva's wakefulness product, Nuvigil (armodafinil) tablets. These settlements...

Sanofi and Medtronic Inc. have signed a memorandum of understanding to enter into a global strategic alliance. The alliance will initially focus on two key priorities: the development of drug-device combinations and delivery of care-management...

Pfizer Inc. has opened a new 280,000 square-foot research and development (R&D) hub in Cambridge, Massachusetts. The new Pfizer facilities houses 1,000 employees from three area locations and positions Pfizer in closer proximity...

MorphoSys AG, a provider of human antibody technologies, and Merck Serono, the biopharmaceutical division of Merck KGaA, have signed an agreement to discover and develop therapeutic antibodies against undisclosed immune checkpoints. MorphoSys will...

Pfenex Inc., a clinical-stage biotechnology company developing and commercializing difficult-to-manufacture proteins, filed a registration statement with the US Securities and Exchange Commission on June 6, 2014 for a proposed initial...

The board of directors of the specialty pharmaceutical company, Allergan, Inc., has unanimously rejected the revised unsolicited proposal, dated May 30, 2014, by Pershing Square Capital Management, L.P. , Allergan's largest shareholder, and...